北美保留结肠手术经验:复杂结直肠病变的高级内镜治疗
该研究回顾性分析了2011至2015年间110例因良性但常规内镜无法切除的结直肠病变接受高级内镜治疗的患者。结果显示内镜切除成功率为88.2%,并发症率为11.8%,11.8%的患者需转为结肠切除术,中位随访16个月仅2例腺瘤复发。结论认为高级内镜手术是结肠切除术的安全有效替代方案。
要点
- 对于常规内镜无法切除的复杂良性结直肠病变,ESD或CELS可实现88.2%的成功切除率。
- 高级内镜手术并发症率为11.8%,主要包括迟发出血、穿孔和手术部位感染。
- 11.8%的患者需转为结肠切除术,原因包括技术失败或发现癌变。
核心结论
- 对于常规内镜技术无法切除的复杂癌前病变,高级内镜手术是结肠切除术的安全有效替代方案。
研究设计与样本
- 单中心回顾性研究,基于2011至2015年前瞻性收集的数据库,纳入110例因良性外观但常规内镜无法切除的结直肠病变而转诊评估的患者。
- 患者接受内镜黏膜下剥离术(ESD)并可能联合内镜-腹腔镜联合手术(CELS),若无法内镜切除或怀疑癌则行结直肠切除术。
主要发现
- 110例患者平均年龄64岁,女性55例(50%),中位体重指数29.4 kg/m2。
- 病变中位内镜大小3 cm(范围1.5-6.5),形态为无蒂98例(93%)和有蒂12例(7%)。
- 内镜切除成功率为88.2%(97例),其中ESD 69例,CELS 28例。
- 并发症率为11.8%(13/110),包括迟发出血4例、穿孔3例、器官腔隙手术部位感染2例、表浅手术部位感染1例和术后肠梗阻3例。
- 13例(11.8%)需行结肠切除术,其中技术失败7例、癌6例;中位随访16个月(范围6-41个月)期间2例患者出现腺瘤复发。
临床怎么用
- 对于常规内镜无法切除的复杂良性结直肠病变,可考虑ESD或CELS以保留结肠。
- 需告知患者约11.8%的并发症风险和11.8%的转为结肠切除术风险。
局限性
- 单中心回顾性研究,样本量有限,随访时间较短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Need for colon sparing interventions for premalignant lesions not amenable to conventional endoscopic excision has stimulated interest in advanced endoscopic approaches. The aim of this study was to report a single institution's experience with these techniques. METHODS: A retrospective review was conducted of a prospectively collected database of all patients referred between 2011 and 2015 for colorectal resection of benign appearing deemed endoscopically unresectable by conventional endoscopic techniques. Patients were counseled for endoscopic submucosal dissection (ESD) with possible combined endoscopic-laparoscopic surgery (CELS) or alternatively colorectal resection if unable to resect endoscopically or suspicion for cancer. Lesion characteristic, resection rate, complications, and outcomes were evaluated. RESULTS: 110 patients were analyzed [mean age 64 years, female gender 55 (50%), median body mass index 29.4 kg/m2]. Indications for interventions were large polyp median endoscopic size 3 cm (range 1.5-6.5) and/or difficult location [cecum (34.9%), ascending colon (22.7%), transverse colon (14.5%), hepatic flexure (11.8%), descending colon (6.3%), sigmoid colon (3.6%), rectum (3.6%), and splenic flexure (2.6%)]. Lesion morphology was sessile (N = 98, 93%) and pedunculated (N = 12, 7%). Successful endoscopic resection rate was 88.2% (N = 97): ESD in 69 patients and CELS in 28 patients. Complication rate was 11.8% (13/110) [delayed bleeding (N = 4), perforation (N = 3), organ-space surgical site infection (SSI) (N = 2), superficial SSI (N = 1), and postoperative ileus (N = 3)]. Out of 110 patients, 13 patients (11.8%) required colectomy for technical failure (7 patients) or carcinoma (6 patients). During a median follow-up of 16 months (range 6-41 months), 2 patients had adenoma recurrence. CONCLUSIONS: Advanced endoscopic surgery appears to be a safe and effective alternative to colectomy for patients with complex premalignant lesions deemed unresectable with conventional endoscopic techniques.
引用
- Gorgun E, Benlice C, Abbas MA, et al. Experience in colon sparing surgery in North America: advanced endoscopic approaches for complex colorectal lesions. Surg Endosc. 2018. PMID: 29362906. doi:10.1007/s00464-018-6026-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。